Our Company On August 15, 2025, ReShape Lifesciences Inc. (now known as Vyome Holdings, Inc.) (the Company) completed the merger pursuant to the Agreement and Plan of Merger, dated as of July 8, 2024, as amended (the Merger Agreement), by and among the Company, Raider Lifesciences Inc., a wholly owned subsidiary of the Company (Merger Sub), and Vyome Therapeutics, Inc. (Vyome). Pursuant to the Merger Agreement, Merger Sub merged with and into Vyome, with Vyome surviving the merger as a subsidiar...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-18 | 2025-12-31 | 0001213900-26-029500 | EDGAR | 115K words |
| 2025-04-04 | 2024-12-31 | 0001558370-25-004477 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001558370-24-004559 | EDGAR | — |
| 2023-04-17 | 2022-12-31 | 0001558370-23-006079 | EDGAR | — |
| 2022-04-08 | 2021-12-31 | 0001558370-22-005238 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001558370-21-002923 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001427570-20-000018 | EDGAR | — |
| 2019-02-22 | 2018-12-31 | 0001427570-19-000019 | EDGAR | — |
| 2018-03-05 | 2017-12-31 | 0001427570-18-000013 | EDGAR | — |
| 2017-02-23 | 2016-12-31 | 0001628280-17-001603 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001213900-25-110980 | EDGAR | 31K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011594 | EDGAR | — |
| 2025-05-20 | 2025-03-31 | 0001558370-25-008031 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015732 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001558370-24-012246 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001558370-24-008304 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018344 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001558370-23-013645 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009920 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017869 | EDGAR | — |
| 2022-08-19 | 2022-06-30 | 0001558370-22-013821 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001558370-22-009259 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-25 | 0001213900-26-020387 | EDGAR | 19K words |
| 2026-02-13 | 0001213900-26-015795 | EDGAR | — |
| 2026-01-28 | 0001213900-26-008575 | EDGAR | — |
| 2025-12-23 | 0001213900-25-125310 | EDGAR | — |
| 2025-11-19 | 0001213900-25-112728 | EDGAR | — |
| 2025-10-30 | 0001213900-25-104121 | EDGAR | — |
| 2025-10-03 | 0001213900-25-096156 | EDGAR | — |
| 2025-09-02 | 0001213900-25-082924 | EDGAR | — |
| 2025-08-20 | 0001213900-25-079045 | EDGAR | — |
| 2025-08-19 | 0001213900-25-078603 | EDGAR | — |
241 total filings indexed. 209 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001427570 |
| Ticker | HIND |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://vyometx.com |
| Listed | 2025-08-15 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report